IP Library Granted Patent US 9,796,973
Granted Patent B2
US 9,796,973 · App. 14/113,674 · Granted Oct 24, 2017

Terminator sequence-containing reverse primer for overexpression and linear DNA

Inventors: Rinji Akada (Ube, JP); Hisashi Hoshida (Ube, JP); Mikiko Nakamura (Ube, JP)
Assignee: YAMAGUCHI UNIVERSITY
C12N15/113C12N15/1075C12N15/111C12N15/64C12N15/85C12N2310/531C12N2330/51
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,796,973
App. No.
14/113,674
Granted
Oct 24, 2017
Kind
B2
Abstract

Plasmid vectors have been widely used as a carrier of a DNA sequence capable of expressing a target RNA in cells. However, construction of these plasmid vectors requires technical skill and time. Thus, a quicker and easier method is required therefor. To solve this problem, a method using a linear DNA that has been amplified by the PCR method is examined. However, this method is disadvantageous in that RNA expression in cells is extremely low. Under these circumstances, the present inventors attempted to develop an RNA expression method using a linear DNA which can be produced mainly by using the PCR method alone and which enables a high level of RNA expression. As the results of intensive studies on terminator sequences to be used in a linear DNA, the present inventors found a smallest unit of a terminator sequence enabling linear DNA expression equivalent to that when using a plasmid vector. A linear DNA including the aforesaid terminator sequence can be produced quickly and easily, and enables RNA expression at a higher level. The present invention has been completed based on these findings.

Claims (7)

1. An artificially synthesized double-stranded linear DNA for RNA expression in cells comprising, in order, a promoter sequence, a target RNA-expressing DNA sequence, and a heterologous 30-200 nucleobase terminator sequence, wherein the terminator sequence comprises at least a 30-nucleobase portion of SEQ ID NO: 1 and wherein the terminator sequence includes a sequence of nine connected nucleobases: (A/T/G), (A/T/G), T, A, A, A, (A/T/G/C), (A/T/G/C), (A/G/C).

2. The linear DNA according to claim 1 , wherein the target RNA-expressing DNA sequence is a shRNA-expressing DNA sequence.

3. The linear DNA according to claim 1 , wherein the terminator sequence comprises SEQ ID NO: 1.

4. The linear DNA according to claim 3 , wherein the target RNA-expressing DNA sequence is a shRNA-expressing DNA sequence.

5. The linear DNA according to claim 1 , wherein the terminator sequence comprises SEQ ID NO: 31.

6. The linear DNA according to claim 5 , wherein the target RNA-expressing DNA sequence is a shRNA-expressing DNA sequence.

7. A method for RNA expression, comprising transfecting the linear DNA according to claim 6 into a cell and expressing RNA from the linear DNA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2014
From: AKADA, RINJI; HOSHIDA, HISASHI; NAKAMURA, MIKIKO
To: YAMAGUCHI UNIVERSITY
Reel/Frame 032304/0525 →
Priority Claims (1)
JP 2011-101015 · Apr 28, 2011 · national
Continuity (1)
Related Publication 20140179002A1 · Jun 26, 2014